BLTP1 and Global developmental delay: Surviving patients with KIAA1109 mutations exhibited global developmental delay, mild to moderate learning disability, no development of speech, inability to stand or walk without support, muscle hypotonia, atrophy, stereotypic movements, dysmorphic features and early-onset epilepsy [1].